HCPLive
MAY 26, 2024
The phase 2 NOBLE trial shows pegcetacoplan reduces disease activity in post-transplant C3G and IC-MPGN, with benefits persisting through the 40-week double-blind period.
Frontiers in Cardiovascular Medicine
MAY 26, 2024
ACE2 is the earliest receptor discovered to mediate the entry of SARS-CoV-2. In addition to the receptor, it also participates in complex pathological and physiological processes, including regulating the RAS system, apelin, KKS system, and immune system. In addition to affecting the respiratory system, viral infections also interact with cardiovascular diseases.
Heart Sisters
MAY 26, 2024
Female heart patients would love to believe that all cardiologists are "extremely well prepared" to assess our cardiovascular risks - but is that true?
Cardiovascular Diabetology
MAY 26, 2024
Stress hyperglycemia, which is associated with poor prognosis in patients with acute myocardial infarction (AMI), can be determined using the stress hyperglycemia ratio (SHR). Impaired left ventricular functio.
HCPLive
MAY 26, 2024
In the APPEAR-C3G trial, iptacopan reduced proteinuria by 35.1% in patients with C3 glomerulopathy, with Novartis planning regulatory submissions for C3G before the end of 2024.
Frontiers in Cardiovascular Medicine
MAY 26, 2024
BackgroundAlthough Hypertension (HTN) is considered to be a cardiovascular disease caused by multiple factors, the cause of it is still unknown. In this study, we aim to find out whether circulating immune cell characteristics have an impact on susceptibility to HTN.MethodsThis study employed a comprehensive two-sample Mendelian randomization (MR) analysis to investigate the causal association between immune cell characteristics and HTN.
HCPLive
MAY 26, 2024
Semaglutide 2.4 mg reduces kidney events in SELECT participants, showing renoprotective effects in addition to cardiovascular benefits.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Dr. Paddy Barrett
MAY 26, 2024
If you are like me, you probably wait until the very last minute to take up an offer. Loads of you have taken the opportunity to get access to the Heart Health Express. I hope you are enjoying it. After today, the Heart Health Express version will not be available for purchase. Likely ever. In the future, the EXPRESS course will likely be included as part of the Complete Heart Health Formula.
HCPLive
MAY 26, 2024
Helen Colhoun, MD, discusses the results of a SELECT analysis she presented at the 61st European Renal Association Congress.
Dr. S. Venkatesan MD
MAY 26, 2024
LDL is potrayed as villian de-chief of atheroscerlois and CAD.But, LDL of about 100 to 160 mg concentration is in constant circulation, in a smooth manner serving other physiological vascular functions. The force of evidence that LDL can pierce an Intact endothelium is so huge no one can has the courage to dispute.But, it doesnt happen in majority is the mysterious truth.
HCPLive
MAY 26, 2024
A Q&A with David Kavanagh, MBChB, PhD, on the results of the APPEAR-C3G trial and implications for care moving forward.
Coronary Artery Disease Journal
MAY 26, 2024
Background Patients with cardiovascular disease (CVD) and risk factors have increased rates of adverse events and mortality after hospitalization for coronavirus disease 2019 (COVID-19). In this study, we attempted to identify and assess the effects of CVD on COVID-19 hospitalizations in the USA using a large national database. Methods The current study was a retrospective analysis of data from the US National (Nationwide) Inpatient Sample from 2020.
Med Page Today
MAY 26, 2024
(MedPage Today) -- For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill their prescriptions for the medications they need to control their blood sugar. Without semaglutide.
Expert insights. Personalized for you.
105 
Let's personalize your content